United States · FDA National Drug Code directory
CLARISCAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0407-2943_10209370-babb-44f2-a9db-3e82f54a54d7
- Product NDC
- 0407-2943
- Form
- INJECTION, SOLUTION
- Composition / generic term
- gadoterate meglumine
- Labeler
- GE Healthcare
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191101
- Source listing expiry
- 20271231
Source-listed ingredients
- GADOTERATE MEGLUMINE — 376.9 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, GLASS in 1 BOX (0407-2943-01) / 10 mL in 1 VIAL, GLASS · 0407-2943-01
- 10 VIAL, GLASS in 1 BOX (0407-2943-02) / 15 mL in 1 VIAL, GLASS · 0407-2943-02
- 10 VIAL, GLASS in 1 BOX (0407-2943-05) / 20 mL in 1 VIAL, GLASS · 0407-2943-05
- 10 VIAL, GLASS in 1 BOX (0407-2943-06) / 5 mL in 1 VIAL, GLASS · 0407-2943-06
- 10 SYRINGE, PLASTIC in 1 BOX (0407-2943-12) / 10 mL in 1 SYRINGE, PLASTIC · 0407-2943-12
- 10 SYRINGE, PLASTIC in 1 BOX (0407-2943-17) / 15 mL in 1 SYRINGE, PLASTIC · 0407-2943-17
- 10 SYRINGE, PLASTIC in 1 BOX (0407-2943-22) / 20 mL in 1 SYRINGE, PLASTIC · 0407-2943-22
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →